Indications:

1. Postmenopausal osteoporosis;

2. Chronic renal failure, especially renal osteodystrophy in patients received hemodialysis;

3. Postoperative hypoparathyroidism;

4. Idiopathic hypoparathyroidism;

5. Pseudohypoparathyroidism;

6. Vitamin D-dependent rickets;

7. Hypophosphate vitamin D-resistant rickets, etc.

Type 2 diabetes mellitus;

Reduce postprandial blood glucose in people with impaired glucose tolerance.

It is suitable for treating type 2 diabetes mellitus.

1. Single drug treatment: This product is combined with diet control and exercise to improve blood sugar control of patients with type 2 diabetes mellitus.

2. In combination with metformin hydrochloride: When metformin hydrochloride alone still cannot effectively control blood sugar, this product can be used in combination with metformin hydrochloride to improve blood sugar control of patients with type 2 diabetes mellitus on the basis of diet and exercise.

3. In combination with metformin hydrochloride and sulfonylureas: When the combination of metformin hydrochloride and sulfonylureas still cannot effectively control blood sugar, this product can be combined with metformin hydrochloride and sulfonylureas to improve the blood sugar control of patients with type 2 diabetes on the basis of diet and exercise.

Used for the treatment of type 2 diabetes in adults (middle-aged and elderly) whose blood sugar cannot be satisfactorily controlled by diet alone.

Glucose control drug

Type 2 diabetes mellitus